A natural history comparison of SOD1-mutant patients with amyotrophic lateral sclerosis between Chinese and German populations
Lu Tang(Union Hospital), Albert C. Ludolph(German Center for Neurodegenerative Diseases), Yan Ma(Harbin Medical University), Jochen H. Weishaupt(Universität Ulm), Kathrin Müller(Universität Ulm), Dongsheng Fan(King University), Johannes Dorst(German Center for Neurodegenerative Diseases), Axel Freischmidt(Universität Ulm), Lu Chen(Army Medical University), Xiaolu Liu(Nanjing Agricultural University), Kornelia Günther(Universität Ulm), Sebastian Michels(Universität Ulm)
Cited by 14
Related Papers
Stroke in China: advances and challenges in epidemiology, prevention, and management
|The Lancet Neurology|2019|1.6k
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
|Nature Reviews Neurology|2022|809
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
|Nature Neuroscience|2015|782
Estimated Burden of Stroke in China in 2020
|JAMA Network Open|2023|595
China stroke surveillance report 2021
|Military Medical Research|2023|554